Neoadjuvant chemotherapy less commonly used in breast cancer

Published Date: 02 Mar 2023

Most women will have breast cancer surgery first if the initial consultation is with a surgeon. This study has been published as a preprint and has not yet been peer-reviewed.

Read Full News

Latest News

GSK, Hansoh's Bone Cancer Drug Meets Main Goal in Late-stage Trial

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Liberalized Diet Fails to Match Neutropenic Safety

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

Chordoma Guidance Moves Into Age of Shared Decision-Making

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

FDA Expands Pembrolizumab-Enfortumab Vedotin Regimen in MIBC

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

AI Tool Offers Early Warning System for Drug Shortages

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Todays Updates

Trial Challenges Indefinite Maintenance for Multiple Myeloma

A randomized trial questions whether patients with standard-risk multiple myeloma need indefinite lenalidomide maintenance.

Blinatumomab May Improve Survival in High-Risk Adult B-ALL

A phase 2 trial evaluates the benefit of adding blinatumomab to consolidation therapy in adults with high-risk Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia.

Latest News

GSK on Tuesday said partner Hansoh Pharmaceutical's experimental drug met the main goal ⁠of keeping an aggressive bone cancer from worsening in a late-stage trial, boosting...

Dr Maurie Markman discusses why modifying cancer diets without RCT data poses major risks, highlighting a trial halted due to a 10% spike in serious infections.

A consensus update for chordoma 11 years in the making focuses on a multidisciplinary approach, use of biomarkers and lays out site-specific protocols.

Pembrolizumab plus enfortumab vedotin is now approved for all adults with muscle-invasive bladder cancer undergoing cystectomy.

A new platform developed by researchers at the University of Toronto uses real-world data and AI-enabled forecasting to identify medications that may soon be in short supply.

Amplify, Apply, Advance: Bridging Academic Expertise and Community Practice to Elevate CML Care

News All Time

Aesthetic Medicine

Aesthetic Medicine : The Aesthetic Medicine News & Perspectives presents the latest information on anti-aging treatments, injectable and implantable soft tissue fillers, botulinum toxin treatments, laser surgery, and other treatments to repair and improve the function and cosmetic appearance of skin tissue.

PET-CT Linked to Improved Margin Assessment in Breast Cancer

Researchers compare success rates for addressing positive margins without intraoperative margin assessment with specimen PET-CT in patients with invasive ductal carcinoma.

Water Ablation Shows Early Promise for Prostate Cancer

Early findings show efficacy of water vapor therapy for treating intermediate-risk prostate cancer with minimal procedural complications.

Vacuum-Tech May Improve Outcomes of Kidney Stone Surgery

Vacuum-assisted flexible ureteroscopy may help clear large kidney stones as well as or better than mainstay treatments, with favorable outcomes after surgery.

Patient Requests That Can Put You In a Tough Position

Requests for emotional support animals, disabled parking placards, and, more recently, Medicaid work exemptions can prove challenging for physicians. Here’s what you need to know.

Europe’s Medical Loophole for Banned Doctors

A doctor struck off in France kept practicing in Belgium, exposing how gaps in EU medical oversight can let sanctioned clinicians cross borders.

Rare Adenoid Cystic Breast Cancer in a Woman

A woman with rare breast adenoid cystic carcinoma carries a BRIP1 variant of uncertain significance, highlighting the challenges in genetic risk assessment.

What the FDA's Hormone Therapy Decision Means for Aging Skin

Skin collagen content decreases at a rate of approximately 1%-2% per year in the early postmenopausal period, skin thickness diminishes, barrier function weakens, and moisture retention falters

US FDA Approves Pfizer's Bleeding Disorder Drug for Children

(Corrects paragraph 2 to say Hympavzi is the first non-factor therapy particularly for pediatric patients with hemophilia ⁠B, not all)

Ask the HF Expert: Advanced Therapies

Dr Yash Varma, a chief cardiology fellow, asks Dr Ileana Piña for her insights on when a patient with heart failure should be referred for advanced therapies.

Tile-Based Radiation to Treat Large Brain Metastases?

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions.

Selpercatinib Cuts Recurrence Risk in Early RET+ NSCLC

In the first phase 3 trial of a RET inhibitor as adjuvant therapy, selpercatinib markedly improved event-free survival vs placebo in early-stage RET fusion-positive NSCLC.

More Women With Breast Cancer Can Skip Axillary Dissection

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.

Will PROTEUS Change the Playbook for Radical Prostatectomy?

New data now show that perioperative systemic therapy with apalutamide can improve outcomes after radical prostatectomy.

S1 Episode 4: Managing Heart Failure in ATTR-CM

From narrow volume windows to SGLT2 inhibitors and emerging devices, Drs Kevin Alexander and Sarah Cuddy discuss heart failure care in ATTR-CM.

Coconut Oil

Current evidence supports the use of this botanical agent to promote skin health, but more research is needed to ascertain more varied and curative applications for this popular natural product.

Recommended News For You

Microplastics can cause malignant changes in lung cells

‘Bar Code’ Biopsy From RNA Could Guide Precision Oncology

BMI is linked to heart damage from chemotherapy in breast cancer patients.

Momelotinib, a JAK inhibitor, has FDA approval to treat adult myelofibrosis in anemic patients.

FDA Leaders Explain Their Choice Regarding Cancer Risk Warning in CAR-T Investigation.

Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer

Blinatumomab Plus Chemotherapy New Standard for Children With B-Cell ALL

Recommended Articles For You

Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends 

Boosting Checkpoint Immunotherapy in Hodgkin Lymphoma with JAK Inhibition: Advances & Insights 

Uncovering the Mystery of the Sessile Serrated Adenoma 

Harnessing Artificial Intelligence in Oncology: Innovations in Diagnosis, Treatment, and Patient Care 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

In Patients with Myeloma Who Postpone HSCT, Quadruplet Displays "Excellent Activity.".

2.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

3.

Second opinions don't significantly delay breast cancer treatment

4.

Year in Review: Multiple Myeloma

5.

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

1.

The importance of understanding normal serum osmolality

2.

Unlocking the Secret to Accurate ANC Calculation with This Informative Blog Post

3.

What is Red Cell Distribution Width and Why Should You Care?

4.

Metabolic Vulnerabilities in Solid Tumor Progression

5.

Exploring the Normal Range of Monocytes: A Comprehensive Guide

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

3.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot